Abstract: An image analysis system including at least one processor and at least one memory is provided. The image analysis system is configured to receive image data associated with a brain of a patient, the image data including a first three-dimensional (3D) diffusion weighted imaging (DWI) image acquired using a magnetic resonance imaging (MRI) system and a second 3D DWI image, concurrently provide the first 3D DWI image to a first channel of a trained model and the second 3D DWI image to a second channel of the trained model, receive an indicator associated with the first 3D DWI image and the second 3D DWI image from the model, generate a report based on the indicator, and cause the report to be output to at least one of a memory or a display.

Abstract: An image analysis system including at least one processor and at least one memory is provided. The image analysis system is configured to receive image data associated with a brain of a patient, the image data including a first three-dimensional (3D) diffusion weighted imaging (DWI) image acquired using a magnetic resonance imaging (MRI) system and a second 3D DWI image, concurrently provide the first 3D DWI image to a first channel of a trained model and the second 3D DWI image to a second channel of the trained model, receive an indicator associated with the first 3D DWI image and the second 3D DWI image from the model, generate a report based on the indicator, and cause the report to be output to at least one of a memory or a display.

Abstract: Disclosed herein are assays and methods of diagnosing strokes using glycogen phosphorylase-BB (GPBB) as the biomarker. Specifically, assays and methods are described herein for distinguishing an ischemic brain condition from myocardial infarction, or distinguishing an ischemic brain condition from stroke mimics, or distinguishing an ischemic stroke from a hemorrhagic stroke. The diagnostic results offered by these assays and methods allow early and appropriate treatment for the specific condition. Also disclosed is a method to identify whether a subject having an ischemic stroke exhibits salvageable brain tissue.

Abstract: Methods and systems are described for quantitatively determining a score for a patient having a disorder, e.g. a stroke, in a tissue, such as the brain, by analyzing both the extent and location of damage to the tissue caused by the disorder.

Abstract: Methods and systems are described for quantitatively determining a score for a patient having a disorder, e.g., a stroke, in a tissue, such as the brain, by analyzing both the extent and location of damage to the tissue caused by the disorder.

Abstract: Methods and systems are described for quantitatively determining a score (150) for a patient having a disorder, e.g., a stroke, in a tissue, such as the brain, by analyzing both the extent and location of damage (110, 120, 130 AND 140) to the tissue caused by the disorder.